Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

July 13, 2020

Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials

The Journal of Thoracic and Cardiovascular Surgery
Haobin HuangCheng Xu
July 15, 2020

Drugs Repurposing in High-Grade Serous Ovarian Cancer

Current Medicinal Chemistry
Manuel TorralbaGabriele Grassi
July 21, 2020
Open Access

Brugada syndrome

Acta Cardiologica
Haarika KorliparaSrinivas Pentyala
July 29, 2020
Open Access

Blood Pressure and Risk of Atrial Fibrillation: A Mendelian Randomization Study

MedRxiv : the Preprint Server for Health Sciences
M. C. HymanScott M. Damrauer
July 14, 2020

Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles

Maxence RabiaFrançoise Hullin-Matsuda
July 22, 2020

Different effect of amiodarone and dofetilide on the dispersion of repolarization between well coupled ventricular and Purkinje fibers

Canadian Journal of Physiology and Pharmacology
Tamás Árpádffy-LovasLászló Virág
August 2, 2020
Open Access

Arrhythmogenic Cardiomyopathy: An In-Depth Look at Molecular Mechanisms and Clinical Correlates

Trends in Cardiovascular Medicine
Sarah CostaFirat Duru
July 9, 2020
Case Report
Open Access

Flecainide improves cardiac synchronization in an early infant with Wolff-Parkinson-White syndrome with left ventricular dyssynchrony

Journal of Cardiology Cases
Naofumi F SumitomoMasaru Miura
July 30, 2020

Pharmacogenetic factors affecting β-blocker metabolism and response

Expert Opinion on Drug Metabolism & Toxicology
Cameron D Thomas, Julie A Johnson
July 28, 2020

Emerging Technologies for Pulmonary Vein Isolation

Circulation Research
F Daniel RamirezPierre Jaïs
July 28, 2020
Open Access

Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general clinicians

Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne
Sean SilenoDana M Harris
July 27, 2020

Inhibition of Human Ether-A-Go-Go-Related Gene (hERG) Potassium Current by the Novel Sotalol Analogue, Soestalol

JACC. Clinical Electrophysiology
Tyler ShuggBrian R Overholser
July 15, 2020
Open Access

Molecular characterization of the calcium release channel deficiency syndrome

JCI Insight
David J TesterMichael J Ackerman
July 21, 2020

The Effect of β-Blockers for Burn Patients on Clinical Outcomes: Systematic Review and Meta-Analysis

Journal of Intensive Care Medicine
Nasreen Hassoun-KheirMical Paul
July 20, 2020

Prolonged Continuous Electrocardiographic Monitoring Prior to Transcatheter Aortic Valve Replacement: The PARE Study

JACC. Cardiovascular Interventions
Lluis AsmaratsJosep Rodés-Cabau

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2020 Meta ULC. All rights reserved